The Effect of Rebamipide for the Patients with Reflux Esophagitis and Gastritis.

Trial Profile

The Effect of Rebamipide for the Patients with Reflux Esophagitis and Gastritis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Rebamipide (Primary) ; Esomeprazole
  • Indications Gastritis; Reflux oesophagitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jun 2016 Planned number of patients changed from 450 to 492.
    • 05 Jun 2016 Status changed from recruiting to completed.
    • 06 Dec 2013 Planned number of patients changed from 260 to 240 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top